子宫肉瘤的临床诊断研究进展
Research Progress in Clinical Diagnosis of Uterine Sarcoma
DOI: 10.12677/ACM.2023.13112478, PDF,   
作者: 王 淇*, 郑 健#, 张晓颖:内蒙古医科大学附属医院妇产科,内蒙古 呼和浩特
关键词: 子宫肉瘤临床诊断肿瘤标记物病理Uterine Sarcoma Clinical Diagnosis Tumor Markers Pathology
摘要: 子宫肉瘤是一种少见的、威胁较大的妇科恶性肿瘤,其发病率逐年上升,具有早期诊断困难,恶性程度高,侵袭性强,复发率高,预后差等特点。由于缺乏具有早期临床诊断意义的影像特征和肿瘤标记物,且在病变早期难以获得明确的肿瘤组织病理标本,因此在诊断上存在一定的难度,也容易出现误诊的情况。因此,目前子宫肉瘤的术前临床诊断仍然是个难题。本文概述子宫肉瘤从流行病学特点、临床表现、实验室检查、影像学及病理学等方面的临床诊断指标,结合多种指标综合分析有助于子宫肉瘤临床诊断的手段和方法。
Abstract: Uterine sarcoma is a rare and threatening gynecological malignant tumor. Its incidence rate is in-creasing year by year. It is characterized by difficult early diagnosis, high malignancy, strong inva-sion, high recurrence rate, and poor prognosis. Due to the lack of imaging features and tumor markers with early clinical diagnostic significance, and the difficulty in obtaining clear pathological specimens of tumor tissue in the early stages of the disease, there are certain difficulties in diagno-sis and misdiagnosis is also prone to occur. Therefore, the preoperative clinical diagnosis of uterine sarcoma remains a challenge at present. This article provides an overview of clinical diagnostic in-dicators for uterine sarcoma from the perspectives of epidemiological characteristics, clinical mani-festations, laboratory examinations, imaging, and pathology. Combined with multiple indicators, comprehensive analysis is helpful in the clinical diagnosis of uterine sarcoma.
文章引用:王淇, 郑健, 张晓颖. 子宫肉瘤的临床诊断研究进展[J]. 临床医学进展, 2023, 13(11): 17671-17675. https://doi.org/10.12677/ACM.2023.13112478

参考文献

[1] In, J.B. and Young, S.K. (2022) Diagnostic Performance of 18F-FDG PET or PET/CT in Differential Diagnosis of Uterine Leiomyomas and Uterine Sarcomas: Systematic Review and Meta-Analysis of the Literature. Clinical and Translational Imaging, 10, 301-309.
[2] Hayashi, T., Sano, K., Yaegashi, N., et al. (2023) Characteristic of Endome-trial Stromal Sarcoma by Algorithm of Potential Biomarkers for Uterine Mesenchymal Tumor. Current Issues in Molec-ular Biology, 45, 6190-6201.
[3] Akira, K., Hiroshi, Y., Hitoshi, T., et al. (2023) Clinical Characteristics and Prognos-tic Factors of Endometrial Stromal Sarcoma and Undifferentiated Uterine Sarcoma Confirmed by Central Pathologic Re-view: A Multi-Institutional Retrospective Study from the Japanese Clinical Oncology Group. Gynecologic Oncology, 176, 82-89. [Google Scholar] [CrossRef] [PubMed]
[4] Andrea, G., Tullio, D.G., Giorgio, B., et al. (2023) Uterine Sar-comas: A Critical Review of the Literature. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 287, 166-170. [Google Scholar] [CrossRef] [PubMed]
[5] Raza, S.K., Muhammad, S.S., Tamana, A., et al. (2023) Prog-nostic Factors, Oncological Treatment and Outcomes of Uterine Sarcoma: 10 Years’ Clinical Experience from a Tertiary Care Center in Pakistan. BMC Cancer, 23, Article No. 510. [Google Scholar] [CrossRef] [PubMed]
[6] Maria, A.K., Alessandra, T., Annkathrin, B., et al. (2023) High Negative Prediction for the Basel Sarcoma Score: Sonographic Assessment of Features Suspicious of Uterine Sarcoma. Gynecologic Oncology, 174, 182-189. [Google Scholar] [CrossRef] [PubMed]
[7] 李丹, 陈文直. 子宫肉瘤的术前诊断研究[J]. 医学信息, 2020, 33(3): 34-37.
[8] 周虎, 陈雨, 王家飞, 等. 术前外周血标志物对子宫肉瘤的联合诊断价值分析[J]. 安徽医学, 2020, 41(7): 751-754.
[9] 张璐芳, 蔡晶, 黄邦杏, 等. 术前如何鉴别诊断子宫肉瘤与子宫肌瘤[J]. 中国实用妇科与产科杂志, 2019, 35(8): 861-864. [Google Scholar] [CrossRef
[10] 陈思蕾, 王光伟, 赵万成, 等. 子宫肉瘤的术前诊断[J]. 国际生殖健康/计划生育杂志, 2019, 38(3): 257-260.
[11] 周花. 磁共振动态增强扫描联合扩散加权成像诊断子宫肉瘤的临床价值[J]. 中国当代医药, 2022, 29(25): 9-12.
[12] 王正, 宋波. 子宫肉瘤的临床病理诊断[J]. 大连医科大学学报, 2022, 44(4): 289-294+300.
[13] 中国抗癌协会妇科肿瘤专业委员会. 子宫肉瘤诊断与治疗指南(2021年版) [J]. 中国癌症杂志, 2021, 31(6): 513-519. [Google Scholar] [CrossRef
[14] 徐冬煜, 茹翱. 弥散加权成像联合多普勒超声对子宫肉瘤与子宫肌瘤的鉴别诊断[J]. 中国妇幼保健, 2021, 36(5): 1206-1209. [Google Scholar] [CrossRef